FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 147 filers reported holding FIBROGEN INC in Q2 2016. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,640,000 | -18.2% | 71,400 | 0.0% | 0.58% | -14.4% |
| Q2 2019 | $3,226,000 | -16.9% | 71,400 | 0.0% | 0.68% | -20.9% |
| Q1 2019 | $3,881,000 | +17.5% | 71,400 | 0.0% | 0.86% | +4.1% |
| Q4 2018 | $3,304,000 | -23.8% | 71,400 | 0.0% | 0.82% | -7.2% |
| Q3 2018 | $4,338,000 | -3.0% | 71,400 | 0.0% | 0.89% | -9.7% |
| Q2 2018 | $4,470,000 | +35.5% | 71,400 | 0.0% | 0.98% | +34.1% |
| Q1 2018 | $3,299,000 | -2.5% | 71,400 | 0.0% | 0.73% | -2.3% |
| Q4 2017 | $3,384,000 | -11.9% | 71,400 | 0.0% | 0.75% | -16.9% |
| Q3 2017 | $3,841,000 | +66.6% | 71,400 | 0.0% | 0.90% | +55.4% |
| Q2 2017 | $2,306,000 | +165.7% | 71,400 | +102.8% | 0.58% | +134.3% |
| Q1 2017 | $868,000 | +15.3% | 35,200 | 0.0% | 0.25% | -6.1% |
| Q4 2016 | $753,000 | +3.3% | 35,200 | 0.0% | 0.26% | 0.0% |
| Q3 2016 | $729,000 | +26.1% | 35,200 | 0.0% | 0.26% | +20.0% |
| Q2 2016 | $578,000 | -22.8% | 35,200 | 0.0% | 0.22% | -13.0% |
| Q1 2016 | $749,000 | – | 35,200 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 1,735,677 | $93,379,000 | 12.44% |
| Omega Fund Management, LLC | 314,348 | $16,912,000 | 9.57% |
| Opaleye Management Inc. | 360,000 | $19,368,000 | 6.85% |
| NEXTHERA CAPITAL LP | 217,329 | $11,692,000 | 3.01% |
| Monashee Investment Management LLC | 122,300 | $6,580,000 | 2.49% |
| Hillhouse Capital Management | 2,486,196 | $133,757,000 | 2.21% |
| DOHENY ASSET MANAGEMENT /CA | 50,925 | $2,740,000 | 1.26% |
| Sicart Associates LLC | 31,072 | $1,672,000 | 1.20% |
| Iguana Healthcare Management, LLC | 80,000 | $4,304,000 | 1.19% |
| Rhenman & Partners Asset Management AB | 145,500 | $7,828,000 | 1.00% |